Weight Management
GLP-1 Tirzepatide
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a dual GIP/GLP-1 receptor agonist offering sustained weight management through weekly injection.
Indications
Weight Management
- — Dual action weight management
- — Sustained results
- — Metabolic support
Price
$400
Strength
Medication Details
30 mg
Concentration: 0.1 mg/unit
Bacteriostatic Water 3 mL
Dosing
Once weekly
Administration
Subcutaneous
Injection Technique
- • Inject subcutaneously into abdomen, thigh, or upper arm
- • Rotate injection sites
- • Clean site, pinch skin, inject at 90° angle
- • Dispose of syringe in sharps container
Missed Dose
- • Take within 5 days if remembered
- • If more than 5 days, skip and resume weekly schedule
- • Do not double dose
Storage & Handling
Refrigerate after reconstitution (36°F–46°F / 2°C–8°C). Do not freeze. Protect from light. Discard after 90 days.
Notes
Dual GIP/GLP-1 receptor agonist.
Consult your prescribing Healthcare Provider for dosing adjustments.
Disclaimer
This medication is compounded and provided for use only under the supervision of a licensed healthcare provider. Use only as prescribed. Individual results may vary.
Version 2.2 | Effective Date: January 31, 2026
Physician-reviewed before dispensing
Medical records maintained
Telehealth consultation available
